Abstract
Background: To better understand the unexplained ∼60% of the genomic architecture of breast cancer susceptibility, we undertook germline whole exome sequencing (WES) of 2,135 BRCA-negative female breast cancer cases. Our series was highly enriched for early-onset, bilateral, family history of disease and concomitant ovarian cancer, substantially boosting power for discovery.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have